Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy [Phase 2]
Phase 2 trial evaluating cognitive behavioral therapy with or without armodafinil for insomnia and fatigue in cancer survivors post-chemothe…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen [Phase 3]
Phase 3 clinical trial evaluating ondansetron with or without dexamethasone to prevent vomiting in patients receiving radiation to the upper…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: A Study of LY2228820 in Participants With Advanced Cancer [Phase 1]
Phase 1 study of LY2228820 in participants with advanced cancer has completed; results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain [Phase 4]
Phase 4 trial comparing titration efficacy and safety of controlled-release versus immediate-release oxycodone in moderate to severe cancer …
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain [Phase 4]
Phase 4 trial assessing safety and tolerability of oxycodone in patients with moderate to severe cancer pain has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports [Phase 3]
Phase 3 trial updating rivaroxaban for thromboprophylaxis in high-risk cancer patients with totally implantable ports is in progress with un…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients [Phase 4]
Phase 4 trial updating timing of granulocyte colony-stimulating factor (G-CSF) after chemotherapy in pediatric patients to assess outcomes.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206) [Phase 1, Phase 2]
Phase 1/2 trial of azacitidine combined with pembrolizumab and epacadostat in advanced solid tumors was terminated. Results were posted in M…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Clinical Trials Education Program for Hispanic Americans [Phase 3]
Phase 3 clinical trial update for a cancer education program conducted with Hispanic Americans; trial status is completed.
-
EMA withdrawal · 2020-03-02EMA Withdrawn: Varuby (rolapitant) — TESARO Bio Netherlands B.V.
EMA has withdrawn Varuby (rolapitant) from the market in the Netherlands/EMA record; the withdrawal concerns vomiting, nausea, and cancer in…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO [Phase 2]
A Phase 2 randomized trial evaluating an innovative custom ankle-foot orthosis (AFO) for efficacy, acceptability, and perceived benefit in i…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments [Phase 2]
Phase 2 trial update for Supersaturated Calcium Phosphate Oral Rinse (Caphosol) assessing prevention of oral mucositis in children undergoin…
-
FDA approval · 2020-02-12FDA Approved: UDENYCA — Supplemental Application (Accord BioPharma, Inc.)
FDA approved a supplemental Biologics License Application for UDENYCA (pegfilgrastim-cbqv) submitted by Accord BioPharma, Inc., expanding it…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 dose-escalation study of GSK2820151 in advanced or recurrent solid tumors has been terminated; results posted.
-
FDA approval · 2020-02-10FDA Approved: FOSAPREPITANT — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for fosaprepitant submitted by Novadoz Pharmaceuticals LLC to expand its labeling.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia [Phase 2, Phase 3]
Phase 2/3 trial assessing mirtazapine for cancer-associated anorexia-cachexia in advanced cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Intravenous Iron Injection in Cancer Patients With Anemia [Phase 3]
Phase 3 trial update on intravenous iron injection for cancer-related anemia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis [Phase 2]
Phase 2 clinical trial update investigating short course radiotherapy for unresectable rectal cancer with liver metastasis.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001) [Phase 1]
Phase 1 trial updating safety, tolerability, and pharmacokinetics of MK-7252 in healthy adults completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Vitamin D and Omega-3 Trial (VITAL) [Phase 3]
Phase 3 VITAL trial update reporting results for vitamin D and omega-3 fatty acids in cancer and cardiovascular disease; results posted Janu…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Vitamin D and Omega-3 Trial (VITAL) [Phase 3]
Phase 3 trial update for Vitamin D and Omega-3 (VITAL) study, with results posted; ongoing status in inactive recruitment for cancer and car…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Improving Communication Between Cancer Patients & Oncologists [NA]
Clinical trial update on improving communication between cancer patients and oncologists. Study status completed with results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Clinical Study of Granulocyte Infusion for Advanced Cancer [Phase 1, Phase 2]
Clinical study update on granulocyte infusion for advanced cancer (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Ivabradine to Prevent Anthracycline-induced Cardiotoxicity [Phase 3]
A Phase 3 clinical trial evaluating ivabradine to prevent cardiotoxicity from anthracycline chemotherapy in patients with cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating co-treatment with GnRH analogs to protect ovarian reserve in young women receiving alkylating chemotherap…